• Info
  • Insider Ownership

Insider Trading & Ownership of Paul J. Clancy

Location
Madison, WI
Summary
The estimated net worth of Paul J. Clancy is at least $2,468,228 dollars as of 02 Apr 2026. Paul J. Clancy is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $2.34M. Paul J. Clancy is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $123.3K.
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Paul J. Clancy and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Paul J. Clancy has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,468,228.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: INCYTE CORP ($2,344,898).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Paul J. Clancy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INCY INCYTE CORP Director $2,344,898 31 Mar 2026
AGIO AGIOS PHARMACEUTICALS, INC. Director $123,330 21 Jun 2022
EXAS EXACT SCIENCES CORP Director $0 23 Mar 2026
SION Sionna Therapeutics, Inc. Director 12 Jun 2025
XLO Xilio Therapeutics, Inc. Director 11 Jun 2025

Insider Transactions Reported by Paul J. Clancy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored